Need professional-grade analysis? Visit stockanalysis.com
$609.95M
N/A
N/A
N/A
Healius Limited (PHCRF) trades on United States in USD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at $0.84.
Over the past year, PHCRF has traded between a low of $0.39 and a high of $0.84. The stock has gained 117.2% over this period. It is currently 117.2% above its 52-week low.
Healius Limited has a market capitalization of $609.95M.
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
Side-by-side comparison against top Healthcare peers.